CA1041424A - Isolation des facteurs de coagulation dans des produits biologiques - Google Patents

Isolation des facteurs de coagulation dans des produits biologiques

Info

Publication number
CA1041424A
CA1041424A CA199,415A CA199415A CA1041424A CA 1041424 A CA1041424 A CA 1041424A CA 199415 A CA199415 A CA 199415A CA 1041424 A CA1041424 A CA 1041424A
Authority
CA
Canada
Prior art keywords
factor
fibrinogen
cross
linked
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA199,415A
Other languages
English (en)
Other versions
CA199415S (en
Inventor
Lars-Olov Andersson
Hakan Borg
Elisabeth Ehrenberg
Nanna Forsman
Gunnar Hanshoff
Goran Lindroos
Maggie Miller-Andersson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phadia AB
Original Assignee
Kabi AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi AB filed Critical Kabi AB
Priority to CA199,415A priority Critical patent/CA1041424A/fr
Application granted granted Critical
Publication of CA1041424A publication Critical patent/CA1041424A/fr
Expired legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CA199,415A 1974-05-09 1974-05-09 Isolation des facteurs de coagulation dans des produits biologiques Expired CA1041424A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA199,415A CA1041424A (fr) 1974-05-09 1974-05-09 Isolation des facteurs de coagulation dans des produits biologiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA199,415A CA1041424A (fr) 1974-05-09 1974-05-09 Isolation des facteurs de coagulation dans des produits biologiques

Publications (1)

Publication Number Publication Date
CA1041424A true CA1041424A (fr) 1978-10-31

Family

ID=4099971

Family Applications (1)

Application Number Title Priority Date Filing Date
CA199,415A Expired CA1041424A (fr) 1974-05-09 1974-05-09 Isolation des facteurs de coagulation dans des produits biologiques

Country Status (1)

Country Link
CA (1) CA1041424A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016084097A1 (fr) 2014-11-13 2016-06-02 Hemarus Therapeutics Ltd. Procédé de production de fibrinogène et de thrombine
CN112912725A (zh) * 2018-10-25 2021-06-04 Tl基因体科技株式会社 使用微通道对血液进行预处理以对血细胞进行分级

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016084097A1 (fr) 2014-11-13 2016-06-02 Hemarus Therapeutics Ltd. Procédé de production de fibrinogène et de thrombine
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
CN112912725A (zh) * 2018-10-25 2021-06-04 Tl基因体科技株式会社 使用微通道对血液进行预处理以对血细胞进行分级

Similar Documents

Publication Publication Date Title
US3920625A (en) Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US4022758A (en) Isolation of coagulation factors I and VIII from biological material
US3842061A (en) Method for isolation of antithrombin from animal tissue materials by adsorption on sulfated carbohydrate gel
US4086222A (en) Method of isolating albumin from blood products
US3631018A (en) Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
RU1837880C (ru) Способ разделени белков крови
US4495175A (en) Preparation of highly purified human antihemophilic factor
CA1126652A (fr) Preparation d'antithrombine et procede de production
US3682881A (en) Fractionation of plasma using glycine and polyethylene glycol
US4341764A (en) Method of preparing fibronectin and antihemophilic factor
PL168353B1 (pl) Sposób wytwarzania zatezonego, standaryzowanego ludzkiego c z y n n i k a von Willebranda o wysokiej czystosci PL PL PL PL PL PL PL
CA2024667C (fr) Procede de preparation d'un concentre de complexe de facteur viii de coagulation sanguine et de facteur de willebrnad a partir de plasma total
US4404132A (en) Blood coagulation promoting product
CA2006658C (fr) Une substance anticoagulante tiree de l'urine
US4470969A (en) Process for producing a concentrate of coagulation factors VII and VIIa
JPH06511018A (ja) 血漿分画精製法
CA1107649A (fr) Methode de separation d'une preparation de facteur ix du plasma
US4455300A (en) Fibronectin compositions
CA1041424A (fr) Isolation des facteurs de coagulation dans des produits biologiques
EP0245875A2 (fr) Méthode pour la purification du facteur VIII
US4361510A (en) Blood coagulation promoting product
US5760183A (en) Process for the manufacture of very high-purity antithaemophilic factor (FVIIIC), and von Willebrand factor, and pharmaceutical compositions containing same
US5047503A (en) Thrombin-binding substance and process for its preparation
CN113652414B (zh) 一种高纯人凝血酶的制备方法
CN108660126A (zh) 一种冻干人凝血酶的制备工艺